Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicenter Controlled Phase III Study of Postoperative Adjuvant Therapy for Stage II/IIIA Gastric Cancer Using TS-1 Alone or TS-1+PSK Combined Therapy

NCT00216034 is registered in ClinicalTrials.gov with Hokuriku-Kinki Immunochemotherapy Study Group as lead sponsor.

NCT NCT00216034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00216034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicenter Controlled Phase III Study of Postoperative Adjuvant Therapy for Stage II/IIIA Gastric Cancer Using TS-1 Alone or TS-1+PSK Combined Therapy
Lead sponsor
Hokuriku-Kinki Immunochemotherapy Study Group
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
February 29, 2016
Enrollment
255 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer